|
Benjamin Sullivan is a co-founder of the Company. Prior to obtaining his Ph.D. in Bioengineering at the University of California, San Diego, Benjamin spent six years researching effects of DED on molecular profiles of the tear film while at the Schepens Eye Research Institute, an affiliate of Harvard Medical School. Prior to that, he graduated from Boston University in 1997 with a B.S. (summa cum laude) in Biomedical Engineering. Benjamin has explored various aspects of the role of androgens within dry eye and has published several articles pertaining to the characterization of lipid distributions within dry eye patients. His current work is focused on applied electromechanical phenomenaat the nanoscale with an emphasis on improving specificity of diagnostic assays. | 